Legal Representation
Attorney
Eric Lamb
USPTO Deadlines
Next Deadline
45 days remaining
Abandonment Notice E-Mailed - No Use Statement Filed
Due Date
August 30, 2025
Application History
27 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 30, 2025 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Jun 30, 2025 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jun 28, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 27, 2025 | NOAC | E | CORRECTED NOA E-MAILED | Loading... |
| Jun 27, 2025 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Jun 27, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jun 26, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Dec 4, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Sep 24, 2024 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| Sep 24, 2024 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Sep 24, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 23, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Mar 26, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 30, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 30, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 10, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 27, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 26, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 26, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 26, 2023 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jul 31, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 26, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 26, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 26, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 16, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 17, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 4, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Diagnostic preparations for medical purposes; Drug delivery agents in the form of powders, tablets, capsules, solutions, cells and nanoparticles that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Tumor suppressing agents; Pharmaceutical products for the prevention and treatment of cancer; Medicines for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Chemical preparations for pharmaceutical or medical purposes, namely, for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Biological preparations for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Biochemical medicines for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor
Classification
International Classes
005